BSE Small Cap News and Updates

Name: Latest research reports of Gravita India Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Gravita India Ltd.
Rating: 5
Author: ICICI Securities Limited

Keep track of all breaking news on BSE Small Cap from all sources in a single place.

Load latest

Gravita India Ltd.

06 May 2025

1880.10

-1.34%

Good showing; sticking to growth plan

Buy: Gravita India Ltd.

Target

ICICI Securities Limited

Gravita India’s (GRAV) performance was in line with our estimates. EBITDA (including hedging gains) was up 22% YoY at INR 1.06bn. EBITDA margin (adj.) was up 20bps YoY (30bps QoQ) at 10.3%. Lead sales volume rose 12.3% YoY at 45.6kt.

Gravita India Ltd. is trading below its 100 day SMA of 1941.3

Nuvoco Vistas Corporation Ltd.

06 May 2025

344.25

0.44%

Debt cloud lingers, but margins shine through

Hold: Nuvoco Vistas Corporation ...

Recommendation Target

ICICI Securities Limited

Q4FY25 turned out to be a dream quarter for Nuvoco Vistas Corp (Nuvoco) with an all-time high EBITDA (up 12% YoY), being 24% ahead of our estimate (driven by beat across realisation and cost); and net debt retreated further to INR 36.4bn (down ~INR 4bn YoY).

Nuvoco Vistas Corporation Ltd. is trading above all available SMAs

V-Mart Retail Ltd.

06 May 2025

3461.60

1.61%

Result Update:V-Mart Retail

Buy: V-Mart Retail Ltd.

Target

Axis Direct

With a 19% upside potential from the CMP, we maintain our BUY rating on the stock.

V-Mart Retail Ltd. is trading below its 150 day SMA of 3551.0

Gravita India Ltd.

06 May 2025

1880.10

-1.34%

Result Update:Gravita India

Buy: Gravita India Ltd.

Target

Axis Direct

We maintain our BUY recommendation on the stock.

Number of MF schemes increased from 8 to 14 in Mar 2025 qtr.

Epigral Ltd.

06 May 2025

1811.20

0.89%

In-line quarter; volume growth guidance maintained

Buy: Epigral Ltd.

Target

Emkay

Epigral posted in-line results, with revenue/EBITDA/PAT up 20%/12%/12% YoY. This was largely led by improvement in ECUs in the caustic soda business and higher realizations for ECH (because of ADD), volume growth in the derivatives and specialty segment (CPVC, ECH).

Epigral Ltd. has an average target of 2344.50 from 2 brokers.

Voltamp Transformers Ltd.

06 May 2025

7795.00

0.13%

Strong player in distribution space; retain with lower TP

Buy: Voltamp Transformers Ltd.

Target

Emkay

We maintain BUY on Voltamp Transformers (VAMP) while cutting our TP by ~15% to Rs11,350 (upside: 39%) from Rs13,350 earlier. VAMP’s Q4FY25 results were ahead of estimates due to higher than estimated volume and realization.

Number of FII/FPI investors decreased from 215 to 194 in Mar 2025 qtr

Ethos Ltd.

06 May 2025

2475.80

3.14%

In-line, strong Q4; WC increase key monitorable

Buy: Ethos Ltd.

Target

Emkay

Ethos’s Q4 EBITDA is in-line, with margin up by 80bps offsetting the 6% miss on revenue. Despite this, revenue growth was a decent 23%/25% in Q4/FY25, led by SSG of 17.4% in FY25 and by new store additions.

Ethos Ltd. average weekly volume is high.

Manappuram Finance Ltd.

05 May 2025

228.45

-0.97%

Bain Capital Seeks CCI Approval To Acquire Stake In Manappuram Finance

NDTV Profit

According to the proposed deal, Bain Capital through its two affiliates -- BC Asia Investments XXV and BC Asia Investments XIV -- will acquire stakes in Manappuram Finance Ltd.